CD40LG and autoimmune thrombocytopenic purpura: Nielsen et al. observed that only 7% of patients with chronic disease course showed glycoprotein‐specific IgM or IgG antibodies, compared to 41% of patients with a transient ITP course (N = 15 vs. N = 37) 47.